Immunohistochemical results showed that compared to that of the model group, the GLUT1 content of NSCLC A549 tumours in the 10 mg/kg α-hederin group was significantly lower (p < 0.01) (Figure 8). This evidence concerns the gene SLC2A1 and non-small cell lung carcinoma.